146 related articles for article (PubMed ID: 36464713)
1. Kavain ablates the radio-resistance of IDH-wildtype glioblastoma by targeting LITAF/NF-κB pathway.
Yu J; Shi J; Yuan F; Yin W; Zeng H; Ge L; Li H; Wang X
Cell Oncol (Dordr); 2023 Feb; 46(1):179-193. PubMed ID: 36464713
[TBL] [Abstract][Full Text] [Related]
2. Kavain Involvement in LPS-Induced Signaling Pathways.
Tang X; Amar S
J Cell Biochem; 2016 Oct; 117(10):2272-80. PubMed ID: 26917453
[TBL] [Abstract][Full Text] [Related]
3. Kavain Inhibition of LPS-Induced TNF-α via ERK/LITAF.
Tang X; Amar S
Toxicol Res (Camb); 2016 Jan; 5(1):188-196. PubMed ID: 26918116
[TBL] [Abstract][Full Text] [Related]
4. Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.
Alafate W; Li X; Zuo J; Zhang H; Xiang J; Wu W; Xie W; Bai X; Wang M; Wang J
CNS Neurosci Ther; 2020 Apr; 26(4):475-485. PubMed ID: 32187449
[TBL] [Abstract][Full Text] [Related]
5. LITAF Enhances Radiosensitivity of Human Glioma Cells via the FoxO1 Pathway.
Huang C; Chen D; Zhu H; Lv S; Li Q; Li G
Cell Mol Neurobiol; 2019 Aug; 39(6):871-882. PubMed ID: 31098771
[TBL] [Abstract][Full Text] [Related]
6. Targeting radiation-tolerant persister cells as a strategy for inhibiting radioresistance and recurrence in glioblastoma.
Gu J; Mu N; Jia B; Guo Q; Pan L; Zhu M; Zhang W; Zhang K; Li W; Li M; Wei L; Xue X; Zhang Y; Zhang W
Neuro Oncol; 2022 Jul; 24(7):1056-1070. PubMed ID: 34905060
[TBL] [Abstract][Full Text] [Related]
7. Spliceosome-regulated RSRP1-dependent NF-κB activation promotes the glioblastoma mesenchymal phenotype.
Li Y; Wang X; Qi S; Gao L; Huang G; Ren Z; Li K; Peng Y; Yi G; Guo J; Yang R; Wang H; Zhang X; Liu Y
Neuro Oncol; 2021 Oct; 23(10):1693-1708. PubMed ID: 34042961
[TBL] [Abstract][Full Text] [Related]
8. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
[TBL] [Abstract][Full Text] [Related]
9. The transcript ENST00000444125 of lncRNA LINC01503 promotes cancer stem cell properties of glioblastoma cells via reducing FBXW1 mediated GLI2 degradation.
Wei P; Jiang J; Xiao M; Zeng M; Liu X; Zhao B; Chen F
Exp Cell Res; 2022 Mar; 412(1):113009. PubMed ID: 34990616
[TBL] [Abstract][Full Text] [Related]
10. miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation.
Hoey C; Ray J; Jeon J; Huang X; Taeb S; Ylanko J; Andrews DW; Boutros PC; Liu SK
Mol Oncol; 2018 Aug; 12(8):1324-1341. PubMed ID: 29845714
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression.
Lan F; Yang Y; Han J; Wu Q; Yu H; Yue X
Int J Oncol; 2016 Feb; 48(2):559-68. PubMed ID: 26648123
[TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
[TBL] [Abstract][Full Text] [Related]
13. NF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma.
McFarland BC; Hong SW; Rajbhandari R; Twitty GB; Gray GK; Yu H; Benveniste EN; Nozell SE
PLoS One; 2013; 8(11):e78728. PubMed ID: 24244348
[TBL] [Abstract][Full Text] [Related]
14. TGF-β induces GBM mesenchymal transition through upregulation of CLDN4 and nuclear translocation to activate TNF-α/NF-κB signal pathway.
Yan T; Tan Y; Deng G; Sun Z; Liu B; Wang Y; Yuan F; Sun Q; Hu P; Gao L; Tian D; Chen Q
Cell Death Dis; 2022 Apr; 13(4):339. PubMed ID: 35418179
[TBL] [Abstract][Full Text] [Related]
15. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.
Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S
Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
17. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma.
Atkinson GP; Nozell SE; Harrison DK; Stonecypher MS; Chen D; Benveniste EN
Oncogene; 2009 Oct; 28(42):3735-45. PubMed ID: 19668231
[TBL] [Abstract][Full Text] [Related]
18. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
19. CRB2 enhances malignancy of glioblastoma via activation of the NF-κB pathway.
Wang Y; Bao G; Zhang M; Xiang J; Zhou H; Wahafu A; Wu W; Ma X; Huo L; Bai X; Xie W; Liu P; Wang M
Exp Cell Res; 2022 May; 414(1):113077. PubMed ID: 35219647
[TBL] [Abstract][Full Text] [Related]
20. GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.
Moreno M; Pedrosa L; Paré L; Pineda E; Bejarano L; Martínez J; Balasubramaniyan V; Ezhilarasan R; Kallarackal N; Kim SH; Wang J; Audia A; Conroy S; Marin M; Ribalta T; Pujol T; Herreros A; Tortosa A; Mira H; Alonso MM; Gómez-Manzano C; Graus F; Sulman EP; Piao X; Nakano I; Prat A; Bhat KP; de la Iglesia N
Cell Rep; 2017 Nov; 21(8):2183-2197. PubMed ID: 29166609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
